Key result
Diabetes mellitus was associated with a significantly higher 3-year all-cause mortality compared to non-diabetic patients with heart failure (33.4% vs. 20.3%, p < 0.0001).
Why the study?
Does the presence of diabetes mellitus increase 3-year mortality in patients with symptomatic chronic systolic heart failure?
Observational (n=1,397)
No
Does the presence of diabetes mellitus increase 3-year mortality in patients with symptomatic chronic systolic heart failure?
Absolute Event Rate: 33.4% vs 20.3%
p-value: p=<0.0001
In patients with symptomatic chronic systolic heart failure, the presence of diabetes mellitus is associated with a significantly higher 3-year mortality rate.
DM associated with higher 3-year mortality in HF despite guideline therapy; leaves open whether targeted strategies improve outcomes.
Introduction: Diabetes mellitus (DM) and heart failure (HF) are two common diseases that often co-exist. Aim: To explore clinical characteristics, management strategies and rates of 3-year mortality among diabetic and nondiabetic patients hospitalised in a highly specialized interventional cardiology centre. Material and methods: We used data from COMMIT-HF (COn-teMporary Modalities In Treatment of Heart Failure), which is a single-centre, observational, prospective registry of patients with symptomatic chronic systolic HF (LVEF < 35%). Data collected included demographics, clinical characteristics, medical history, inpatient therapies and procedures. Follow-up was based on the information acquired from the national healthcare provider. Results: We analysed 1397 patients out of the total of 1798 patients included in the COMMIT-HF registry between 2009 and 2013. We identified 595 (42.6%) diabetic and 802 (57.4%) nondiabetic patients. Compared to patients without DM, patients with type 2 DM had a higher rate of comorbidity. Frequency of death in patients with DM during the 3-year follow-up was significantly higher than in patients without DM (199 (33.4%) vs. 163 (20.3%), p < 0.0001, respectively). Conclusions: In the analysed HF population representing patients receiving typical, everyday clinical care, the prevalence of DM is 42.6%. Diabetes mellitus has deleterious effects on renal function and symptoms as assessed by the New York Heart Association functional class. DM remains associated with increased frequency of death in patients with HF, in spite of recent pharmacological and device-based advances in HF management.
No takes yet. Share an insight, caveat, or question.
Siedlecki et al. (2017) conducted an observational in Heart Failure (n=1,397). Diabetes mellitus vs. Non-diabetic patients was evaluated on All-cause mortality at 3 years (p=<0.0001). Diabetes mellitus was associated with a significantly higher 3-year all-cause mortality compared to non-diabetic patients with heart failure (33.4% vs. 20.3%, p < 0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: